Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: A study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique

Blood

Volumn 97, Issue 3, 2001, Pages 822-825

  Avet Loiseau, Hervé ^a   Daviet, Axelle ^b   Brigaudeau, Christophe ^b   Callet Bauchu, Evelyne ^b   Terré, Christine ^b   Lafage Pochitaloff, Marina ^b   Désangles, François ^b   Ramond, Sylvie ^b   Talmant, Pascaline ^b   Bataille, Régis ^a  

^a INSTITUT DE BIOLOGIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 14Q; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 13; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INTERPHASE; KARYOTYPE; MALE; MONOSOMY; MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0035253869     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.3.822     Document Type: Article

References (22)

1. Plasma cell leukemia: Report on 17 cases
2. Plasma cell leukemia: An evaluation of response to therapy
3. Primary plasma cell leukemia
4. Primary plasma cell leukemia: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics
5. High incidence of translocations t(11;14)(q13;q32) and t(4,14)(p16;q32) in patients with plasma cell malignancies
6. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma
7. Leukemic form of immunocytic dyscrasia/plasma cell leukemia): A study of ten cases and a review of the literature
8. Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis
9. Cytogenetic findings in 200 patients with multiple myeloma
10. Chromosomal analysis in multiple myeloma: Cytogenetic evidence of two different diseases
11. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping
12. Diverse karyotypic abnormalities of the c-myclocus associated with c-myc dysregulation and tumor progression in multiple myeloma
13. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts
14. Chromosome studies in plasma cell leukemia and multiple myeloma in transformation
15. 14q32 Translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma
16. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma
17. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma
18. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11 q and not with other karyotype abnormalities
19. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization
20. Results of high dose therapy for 1000 patients with multiple myeloma: Durable complete remissions and superior survival in the absence of chromosome 13 abnormalities
21. Multiple myeloma and the translocation t(11;14)(q13;q32): A report on 13 cases
22. Cytogenetics in multiple myeloma: A multicenter study of 24 patients with t(11;14)(q13;q32) or its variant